Operating Lease, Right-of-Use Asset of Cyclerion Therapeutics, Inc. from 01 Apr 2019 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cyclerion Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Apr 2019 to 31 Dec 2023.
  • Cyclerion Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2023 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cyclerion Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $0 -$1,218,000 -100% 31 Dec 2023 10-K 05 Mar 2024 2023 FY
Q3 2023 $0 -$1,264,000 -100% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $1,125,000 -$185,000 -14% 30 Jun 2023 10-Q 28 Jul 2023 2023 Q2
Q1 2023 $1,171,000 -$185,000 -14% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $1,218,000 -$184,000 -13% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $1,264,000 -$185,000 -13% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $1,310,000 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $1,356,000 -$41,040,000 -97% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $1,402,000 -$42,000,000 -97% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $1,449,000 -$42,947,000 -97% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q1 2021 $42,396,000 -$9,858,000 -19% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $43,402,000 -$24,735,000 -36% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $44,396,000 -$24,762,000 -36% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $51,306,000 -$19,024,000 -27% 30 Jun 2020 10-Q 03 Aug 2020 2020 Q2
Q1 2020 $52,254,000 -$19,046,000 -27% 31 Mar 2020 10-Q 04 May 2020 2020 Q1
Q4 2019 $68,137,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $69,158,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $70,330,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $71,300,000 01 Apr 2019 10-Q 12 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.